105 related articles for article (PubMed ID: 16019413)
1. Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin.
Hiraki Y; Shukunami C
Connect Tissue Res; 2005; 46(1):3-11. PubMed ID: 16019413
[TBL] [Abstract][Full Text] [Related]
2. Chondromodulin-I and tenomodulin are differentially expressed in the avascular mesenchyme during mouse and chick development.
Shukunami C; Takimoto A; Miura S; Nishizaki Y; Hiraki Y
Cell Tissue Res; 2008 Apr; 332(1):111-22. PubMed ID: 18239943
[TBL] [Abstract][Full Text] [Related]
3. [Chondromodulin-I and its related gene Tenomodulin].
Shukunami C; Oshima Y; Nishizaki Y
Clin Calcium; 2002 Mar; 12(3):356-62. PubMed ID: 15775314
[TBL] [Abstract][Full Text] [Related]
4. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues.
Shukunami C; Oshima Y; Hiraki Y
Biochem Biophys Res Commun; 2005 Jul; 333(2):299-307. PubMed ID: 15950187
[TBL] [Abstract][Full Text] [Related]
5. Chondromodulin-I and tenomodulin: the negative control of angiogenesis in connective tissue.
Shukunami C; Hiraki Y
Curr Pharm Des; 2007; 13(20):2101-12. PubMed ID: 17627542
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I.
Oshima Y; Sato K; Tashiro F; Miyazaki J; Nishida K; Hiraki Y; Tano Y; Shukunami C
J Cell Sci; 2004 Jun; 117(Pt 13):2731-44. PubMed ID: 15150318
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed genes in mandibular condylar and tibial growth cartilages using laser microdissection and fluorescent differential display: chondromodulin-I (ChM-1) and tenomodulin (TeM) are differentially expressed in mandibular condylar and other growth cartilages.
Watahiki J; Yamaguchi T; Enomoto A; Irie T; Yoshie K; Tachikawa T; Maki K
Bone; 2008 Jun; 42(6):1053-60. PubMed ID: 18337200
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes.
Oshima Y; Shukunami C; Honda J; Nishida K; Tashiro F; Miyazaki J; Hiraki Y; Tano Y
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1814-23. PubMed ID: 12714610
[TBL] [Abstract][Full Text] [Related]
9. Chondromodulin-I as a novel cartilage-specific growth-modulating factor.
Hiraki Y; Shukunami C
Pediatr Nephrol; 2000 Jul; 14(7):602-5. PubMed ID: 10912526
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of Tenomodulin and Chondromodulin-1 at the insertion site of the tendon reflects a phenotypic transition of the resident cells.
Yukata K; Matsui Y; Shukunami C; Takimoto A; Hirohashi N; Ohtani O; Kimura T; Hiraki Y; Yasui N
Tissue Cell; 2010 Apr; 42(2):116-20. PubMed ID: 20334886
[TBL] [Abstract][Full Text] [Related]
11. Tenomodulin is necessary for tenocyte proliferation and tendon maturation.
Docheva D; Hunziker EB; Fässler R; Brandau O
Mol Cell Biol; 2005 Jan; 25(2):699-705. PubMed ID: 15632070
[TBL] [Abstract][Full Text] [Related]
12. Altered fracture callus formation in chondromodulin-I deficient mice.
Yukata K; Matsui Y; Shukunami C; Takimoto A; Goto T; Nishizaki Y; Nakamichi Y; Kubo T; Sano T; Kato S; Hiraki Y; Yasui N
Bone; 2008 Dec; 43(6):1047-56. PubMed ID: 18793763
[TBL] [Abstract][Full Text] [Related]
13. Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage.
Kusafuka K; Hiraki Y; Shukunami C; Kayano T; Takemura T
Acta Histochem; 2002; 104(2):167-75. PubMed ID: 12086337
[TBL] [Abstract][Full Text] [Related]
14. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
15. A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics: expression, purification, and characterization.
Smirnoff P; Roiz L; Angelkovitch B; Schwartz B; Shoseyov O
Cancer; 2006 Dec; 107(12):2760-9. PubMed ID: 17109444
[TBL] [Abstract][Full Text] [Related]
16. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage.
Hiraki Y; Inoue H; Iyama K; Kamizono A; Ochiai M; Shukunami C; Iijima S; Suzuki F; Kondo J
J Biol Chem; 1997 Dec; 272(51):32419-26. PubMed ID: 9405451
[TBL] [Abstract][Full Text] [Related]
17. A functional role of the glycosylated N-terminal domain of chondromodulin-I.
Kondo J; Shibata H; Miura S; Yamakawa A; Sato K; Higuchi Y; Shukunami C; Hiraki Y
J Bone Miner Metab; 2011 Jan; 29(1):23-30. PubMed ID: 20506028
[TBL] [Abstract][Full Text] [Related]
18. Role of cartilage-derived anti-angiogenic factor, chondromodulin-I, during endochondral bone formation.
Shukunami C; Hiraki Y
Osteoarthritis Cartilage; 2001; 9 Suppl A():S91-101. PubMed ID: 11680695
[TBL] [Abstract][Full Text] [Related]
19. Tick troponin I-like molecule is a potent inhibitor for angiogenesis.
Fukumoto S; Sakaguchi T; You M; Xuan X; Fujisaki K
Microvasc Res; 2006 May; 71(3):218-21. PubMed ID: 16631826
[TBL] [Abstract][Full Text] [Related]
20. Immobilization-induced cartilage degeneration mediated through expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and chondromodulin-I.
Sakamoto J; Origuchi T; Okita M; Nakano J; Kato K; Yoshimura T; Izumi S; Komori T; Nakamura H; Ida H; Kawakami A; Eguchi K
Connect Tissue Res; 2009; 50(1):37-45. PubMed ID: 19212851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
